false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Didactics
Diagnosis and Referral of GTD
Diagnosis and Referral of GTD
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The presentation focused on Gestational Trophoblastic Disease (GTD), which refers to a group of tumors originating from the placenta. These tumors can develop after any pregnancy event, including molar pregnancies and choriocarcinomas. Diagnosis is essential, typically involving checking HCG levels and performing ultrasounds, as GTD features abnormal cells in the placenta. The presentation stressed the significance of referring GTD patients to specialized centers to optimize management and reduce complications. Different regions experience varying GTD prevalence rates, influenced by genetic factors. After evacuation, continuous monitoring of HCG levels is crucial to prevent progression to malignant forms like gestational trophoblastic neoplasia. Referral to reference centers is vital, especially for high-risk disease cases, due to the specialized knowledge required for accurate management. Lastly, the speaker highlighted International GTD Day on September 3, dedicated to raising awareness and support for those affected by GTD.
Asset Subtitle
Kevin Elias
February 2025
Keywords
Gestational Trophoblastic Disease
placenta tumors
HCG levels
specialized centers
genetic factors
International GTD Day
Contact
education@igcs.org
for assistance.
×